--- title: "NXL.US (NXL.US) — 相關新聞" type: "Symbol" locale: "zh-HK" url: "https://longbridge.com/zh-HK/quote/NXL.US/news.md" symbol: "NXL.US" name: "NXL.US" parent: "https://longbridge.com/zh-HK/quote/NXL.US.md" datetime: "2026-03-12T14:22:46.660Z" locales: - [en](https://longbridge.com/en/quote/NXL.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/NXL.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/NXL.US/news.md) --- > 支持的語言: [English](https://longbridge.com/en/quote/NXL.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/NXL.US/news.md) # NXL.US (NXL.US) — 相關新聞 ### [Nexalis starts first-in-human trial of inhaled CBD therapy for panic disorder](https://longbridge.com/zh-HK/news/277698955.md) *2026-03-04T00:33:08.000Z* > Nexalis Therapeutics has initiated a Phase 1 first-in-human trial for IRX-616a, an inhaled CBD therapy aimed at treating ### [U.S. stock market quick update: Nexalin Tech down 9.51%, FDA trials and collaborations failed to boost market confidence, technical signals indicate selling risks](https://longbridge.com/zh-HK/news/276933342.md) *2026-02-25T20:17:53.000Z* > Nexalin Tech fell 9.51%; Boston Scientific fell 1.12%, with a trading volume of USD 572 million; Intuitive Surgical rose ### [Nexalin Announces 150-Patient Pivotal HALO Clarity Trial to Support Planned De Novo FDA Submission](https://longbridge.com/zh-HK/news/276930747.md) *2026-02-25T19:33:01.000Z* > Nexalin has announced the initiation of a pivotal trial named HALO™ Clarity, involving 150 patients to support a planned ### [](https://longbridge.com/zh-HK/news/276778755.md) *2026-02-24T19:18:22.000Z* > Nexalin Technology shares are trading higher after the company announced pivotal clinical trial of HALO Clarity for the ### [EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia](https://longbridge.com/zh-HK/news/276736948.md) *2026-02-24T12:50:57.000Z* > Nexalin Technology, Inc. is advancing a pivotal clinical trial for its HALO Clarity treatment aimed at moderate to sever ### [Nexalin supports Congressional support for deep brain neurostimulation research for veterans and neurological disorders.](https://longbridge.com/zh-HK/news/276607351.md) *2026-02-23T13:20:01.000Z* > Nexalin has expressed support for Congressional efforts to advance deep brain neurostimulation research aimed at helping ### [Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders | NXL Stock News](https://longbridge.com/zh-HK/news/276605456.md) *2026-02-23T05:18:00.000Z* > Nexalin Technology, Inc. (Nasdaq: NXL) has praised recent bipartisan Congressional initiatives that enhance federal supp ### [Nexalin and UCSD launch NeuroCare®, an AI virtual clinic for patients with brain health disorders, offering remote physician-monitored neurotherapy subscription models.](https://longbridge.com/zh-HK/news/274985749.md) *2026-02-05T13:38:30.000Z* > A new digital health platform, developed in collaboration with UCSD, is set to revolutionize the treatment of brain-heal